000			01511 a2200457 4500
005			20250514002156.0
264		0	_c20020107
008			200201s 0 0 eng d
022			_a0724-8741
024	7		_a10.1023/a:1011024200280 _2doi
040			_aNLM _beng _cNLM
100	1		_aMitchell, D Y
245	0	0	_aRisedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administration. _h[electronic resource]
260			_bPharmaceutical research _cFeb 2001
300			_a166-70 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAnalysis of Variance
650	0	4	_aArea Under Curve
650	0	4	_aCalcium Channel Blockers _xpharmacokinetics
650	0	4	_aCross-Over Studies
650	0	4	_aEtidronic Acid _xanalogs & derivatives
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aMale
650	0	4	_aMetabolic Clearance Rate
650	0	4	_aMiddle Aged
650	0	4	_aRisedronic Acid
700	1		_aBarr, W H
700	1		_aEusebio, R A
700	1		_aStevens, K A
700	1		_aDuke, F P
700	1		_aRussell, D A
700	1		_aNesbitt, J D
700	1		_aPowell, J H
700	1		_aThompson, G A
773	0		_tPharmaceutical research _gvol. 18 _gno. 2 _gp. 166-70
856	4	0	_uhttps://doi.org/10.1023/a:1011024200280 _zAvailable from publisher's website
999			_c11335604 _d11335604